Header

UZH-Logo

Maintenance Infos

Browse by Creators

Navigate back| Up a level
Export as
Number of items: 18.

Wu, Wanlong; Jordan, Suzana; Graf, Nicole; de Oliveira Pena, Janethe; Curram, John; Allanore, Yannick; Matucci-Cerinic, Marco; Pope, Janet E; Denton, Christopher P; Khanna, Dinesh; Distler, Oliver; EUSTAR collaborators (2019). Progressive skin fibrosis is associated with a decline in lung function and worse survival in patients with diffuse cutaneous systemic sclerosis in the European Scleroderma Trials and Research (EUSTAR) cohort. Annals of the Rheumatic Diseases, 78(5):648-656.

Osthoff, Michael; Jaeger, Veronika K; Heijnen, Ingmar A F M; Trendelenburg, Marten; Jordan, Suzana; Distler, Oliver; Walker, Ulrich A (2019). Role of lectin pathway complement proteins and genetic variants in organ damage and disease severity of systemic sclerosis: a cross-sectional study. Arthritis Research & Therapy, 21:76.

Gindzienska-Sieskiewicz, Ewa; Distler, Oliver; Reszec, Joanna; Jordan, Suzana; Bielecki, Pawel; Sieskiewicz, Andrzej; Sulik, Agnieszka; Lukasik, Malgorzata; Bielecki, Marek; Kowal, Krzysztof; Kowal-Bielecka, Otylia (2019). Increased expression of the TNF superfamily member LIGHT/TNFSF14 and its receptors (HVEM and LTßR) in patients with systemic sclerosis. Rheumatology, 58(3):502-510.

Bütikofer, Simon; Jordan, Suzana; Sauter, Matthias; Hollenstein, Michael; Heinrich, Henriette; Freitas-Queiroz, Natália; Kuntzen, Thomas; Ang, Daphne; Oberacher, Marcos; Maurer, Britta; Schwizer, Werner; Fox, Mark; Distler, Oliver; Misselwitz, Benjamin (2019). Abnormal esophageal motility during a solid test meal in systemic sclerosis-detection even in very early disease and association with disease progression. Neurogastroenterology and Motility, 31(1):e13480.

Wu, Wanlong; Jordan, Suzana; Distler, Oliver (2018). Response to: ‘Will SPAR be useful in the usual patients with scleroderma?’ by Chattopadhyay et al. Annals of the Rheumatic Diseases:Epub ahead of print.

Abignano, Giuseppina; Blagojevic, Jelena; Bissell, Lesley-Anne; et al; Distler, Oliver; Jordan, Suzana (2018). European multicentre study validates enhanced liver fibrosis test as biomarker of fibrosis in systemic sclerosis. Rheumatology:on-line.

Wu, Wanlong; Jordan, Suzana; Distler, Oliver (2018). Response to: 'Can we further SPARkle the SPAR model?' by Kavadichanda. Annals of the Rheumatic Diseases:Epub ahead of print.

Wu, Wanlong; Jordan, Suzana; Becker, Mike Oliver; Dobrota, Rucsandra; Maurer, Britta; Fretheim, Håvard; Ye, Shuang; Siegert, Elise; Allanore, Yannick; Hoffmann-Vold, Anna-Maria; Distler, Oliver (2018). Prediction of progression of interstitial lung disease in patients with systemic sclerosis: the SPAR model. Annals of the Rheumatic Diseases, 77(9):1326-1332.

Graf, Laura; Dobrota, Rucsandra; Jordan, Suzana; Wildi, Lukas Martin; Distler, Oliver; Maurer, Britta (2018). Nodular Regenerative Hyperplasia of the Liver: A Rare Vascular Complication in Systemic Sclerosis. Journal of Rheumatology, 45(1):103-106.

Valentini, Gabriele; Iudici, Michele; Walker, Ulrich A; Jaeger, Veronika K; Baron, Murray; Carreira, Patricia; Czirják, László; Denton, Christopher P; Distler, Oliver; Hachulla, Eric; Herrick, Ariane L; Kowal-Bielecka, Otylia; Pope, Janet; Müller-Ladner, Ulf; Riemekasten, Gabriela; Avouac, Jerome; Frerix, Marc; Jordan, Suzana; Minier, Tünde; Siegert, Elise; Ong, Voon H; Vettori, Serena; Allanore, Yannick (2017). The European Scleroderma Trials and Research group (EUSTAR) task force for the development of revised activity criteria for systemic sclerosis: derivation and validation of a preliminarily revised EUSTAR activity index. Annals of the Rheumatic Diseases, 76(1):270-276.

Stamm, Adriana; Saxer, Stéphanie; Lichtblau, Mona; Hasler, Elisabeth D; Jordan, Suzana; Huber, Lars C; Bloch, Konrad E; Distler, Oliver; Ulrich, Silvia (2016). Exercise pulmonary haemodynamics predict outcome in patients with systemic sclerosis. European Respiratory Journal, 48(6):1658-1667.

Dobrota, Rucsandra; Maurer, Britta; Graf, Nicole; Jordan, Suzana; Mihai, Carina; Kowal-Bielecka, Otylia; Allanore, Yannick; Distler, Oliver (2016). Prediction of improvement in skin fibrosis in diffuse cutaneous systemic sclerosis: a EUSTAR analysis. Annals of the Rheumatic Diseases, 75(10):1743-1748.

Lepri, Gemma; Avouac, Jerome; Airò, Paolo; Anguita Santos, Francisco; Bellando-Randone, Silvia; Blagojevic, Jelena; Garcia Hernàndez, Francisco; Gonzalez Nieto, Jose Antonio; Guiducci, Serena; Jordan, Suzana; Limaye, Vidya; Maurer, Britta; Selva-O'Callaghan, Albert; Riccieri, Valeria; Distler, Oliver; Matucci-Cerinic, Marco; Allanore, Yannick (2016). Effects of rituximab in connective tissue disorders related interstitial lung disease. Clinical and Experimental Rheumatology, 34 Suppl(5):181-185.

Suliman, Yossra A; Dobrota, Rucsandra; Huscher, Dörte; Nguyen-Kim, Thi D L; Maurer, Britta; Jordan, Suzana; Speich, Rudolf; Frauenfelder, Thomas; Distler, Oliver (2015). Pulmonary function tests: high rate of false negatives in the early detection and screening of scleroderma interstitial lung disease. Arthritis and Rheumatology, 67(12):3256-3261.

Jordan, Suzana; Maurer, Britta; Toniolo, Martin; Michel, Beat; Distler, Oliver (2015). Performance of the new ACR/EULAR classification criteria for systemic sclerosis in clinical practice. Rheumatology, 54(8):1454-1458.

Jordan, Suzana; Distler, Jörg H W; Maurer, Britta; Huscher, Dörte; van Laar, Jacob M; Allanore, Yannick; Distler, Oliver (2015). Effects and safety of rituximab in systemic sclerosis: an analysis from the European Scleroderma Trial and Research (EUSTAR) group. Annals of the Rheumatic Diseases, 74(6):1188-1194.

Jordan, Suzana; Chung, James; Distler, Oliver (2013). Preclinical and translational research to discover potentially effective antifibrotic therapies in systemic sclerosis. Current Opinion in Rheumatology, 25(6):679-685.

Klein, Kerstin; Aeschlimann, André; Jordan, Suzana; Gay, Renate; Gay, Steffen; Sprott, Haiko (2012). ATP induced brain-derived neurotrophic factor expression and release from osteoarthritis synovial fibroblasts is mediated by purinergic receptor P2X4. PLoS ONE, 7(5):e36693.

This list was generated on Tue Jun 18 01:36:11 2019 CEST.